NewGenIvf Group Limited Class A ordinary shares
NIVFNewGenIVF Group Limited is a fertility services provider specializing in assisted reproductive technologies and reproductive health services. The company offers comprehensive solutions including IVF treatments, egg donation, fertility preservation, and other related healthcare services. Operating primarily in Asia, NewGenIVF focuses on delivering advanced reproductive procedures with a commitment to patient care and medical innovation.
Company News
NewGenIvf Group acquired advanced cytometry intellectual property, receiving a valuation of $17.9 million, which boosts the company's net asset value and marks a strategic transition from traditional IVF services to a technology-driven service provider.
NewGenDigital, a subsidiary of NewGenIvf Group, has secured a strategic 110,400 sq. ft. plot in Ras Al Khaimah, UAE, and is exploring real world asset tokenization using blockchain technology, with potential sales revenue exceeding $400 million.
NewGenIVF, a fertility services provider in Asia, has terminated its proposed reverse merger transaction with European Wellness Investment Holdings Limited due to the latter's failure to deliver required financial statements by the deadline.
NewGenIvf Group Limited (NIVF) provided an update on its proposed reverse merger with European Wellness Investment Holdings Limited (EWIHL) and the completion of its acquisition of MicroSort Reproductive Technology. The company is evaluating strategic acquisition opportunities to align with its growth strategy.
NewGen, a fertility services provider in Asia, has regained compliance with Nasdaq's minimum bid price requirement and received approval to transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market.
